Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (411-420 of 546) with videos related to

Pageof 55
Sort By:
Discover Oncology|November 19, 2025
Feasibility of different meningioma delineation approaches on [<sup>18</sup>F]SiTATE PET/CT imagingSophie Carina Kunte, Lena M Unterrainer, Simon Lindner, et al.
Molecular Imaging and Biology|August 16, 2018
Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyRudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
Data in Brief|June 13, 2018
Data on specificity of [<sup>18</sup>F]GE180 uptake for TSPO expression in rodent brain and myocardiumMaximilian Deussing, Tanja Blume, Lena Vomacka, et al.
Zeitschrift Fur Medizinische Physik|January 29, 2023
Feasibility of radiomic feature harmonization for pooling of [<sup>18</sup>F]FET or [<sup>18</sup>F]GE-180 PET images of gliomasAdrian Jun Zounek, Nathalie Lisa Albert, Adrien Holzgreve, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2022
Combination of pre-treatment dynamic [<sup>18</sup>F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastomaZhicong Li, Adrien Holzgreve, Lena M Unterrainer, et al.
Molecular Imaging and Biology|July 18, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyRudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
EJNMMI Research|May 3, 2022
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapyCarolin Kitzberger, Rebekka Spellerberg, Volker Morath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2013
Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PETAxel Rominger, Matthias Brendel, Steffen Burgold, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 11, 2023
Biodistribution and dosimetry for combined [<sup>177</sup>Lu]Lu-PSMA-I&T/[<sup>225</sup>Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imagingAstrid Delker, Mirjam Schleske, Grigory Liubchenko, et al.
Theranostics|April 16, 2020
Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (<i>NIS</i>) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cellsMariella Tutter, Christina Schug, Kathrin A Schmohl, et al.
Pageof 55

Showing results (411-420 of 546) with videos related to

Sort By:
Pageof 55
Discover Oncology|November 19, 2025
Feasibility of different meningioma delineation approaches on [<sup>18</sup>F]SiTATE PET/CT imagingSophie Carina Kunte, Lena M Unterrainer, Simon Lindner, et al.
Molecular Imaging and Biology|August 16, 2018
Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyRudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
Data in Brief|June 13, 2018
Data on specificity of [<sup>18</sup>F]GE180 uptake for TSPO expression in rodent brain and myocardiumMaximilian Deussing, Tanja Blume, Lena Vomacka, et al.
Zeitschrift Fur Medizinische Physik|January 29, 2023
Feasibility of radiomic feature harmonization for pooling of [<sup>18</sup>F]FET or [<sup>18</sup>F]GE-180 PET images of gliomasAdrian Jun Zounek, Nathalie Lisa Albert, Adrien Holzgreve, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2022
Combination of pre-treatment dynamic [<sup>18</sup>F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastomaZhicong Li, Adrien Holzgreve, Lena M Unterrainer, et al.
Molecular Imaging and Biology|July 18, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyRudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
EJNMMI Research|May 3, 2022
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapyCarolin Kitzberger, Rebekka Spellerberg, Volker Morath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2013
Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PETAxel Rominger, Matthias Brendel, Steffen Burgold, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 11, 2023
Biodistribution and dosimetry for combined [<sup>177</sup>Lu]Lu-PSMA-I&T/[<sup>225</sup>Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imagingAstrid Delker, Mirjam Schleske, Grigory Liubchenko, et al.
Theranostics|April 16, 2020
Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (<i>NIS</i>) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cellsMariella Tutter, Christina Schug, Kathrin A Schmohl, et al.
Pageof 55